Skip to content

Establishment of Systematic Treatment for Elbow Joint Dysfunction

Establishment of Systematic Treatment for Elbow Joint Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-16010019
Enrollment
Unknown
Registered
2016-11-25
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow joint dysfunction

Interventions

Ulnar nerve disposal group:Whether to move forward the ulnar nerve
Ligament repair group:Place the angle when repaired
Radial head treatment group:Whether the replacement of radial head
Joint treatment group:Whether joint replacement
Drainage Monitoring Group: Whether the use of tranexamic acid
Heterotopic ossification group:Removal of heterotopic ossification time
Heterotopic ossification prevention group:Whether COX-2 inhibitors are used

Sponsors

Shanghai Sixth People's Hospital East Campus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients aged 12-65 years of age, and can be combined with postoperative functional exercise; 2. including traumatic elbow joint dysfunction, congenital deformity elbow joint dysfunction, heterotopic ossification of the brain caused by elbow joint dysfunction, post-burn heterotopic ossification caused by elbow joint dysfunction, rheumatic immune disease Due to elbow joint dysfunction, degenerative arthritis caused by elbow joint dysfunction, and various types of intra-articular infection caused by elbow joint dysfunction in patients; 3. patients with long-term clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. limb with wrist joint dysfunction or ulnar and radial deformity healing of the affected forearm rotation function disorders; 2. patients with mental disorders; 3. patients with other conditions can not cope with the treatment; 4. combined with severe diabetes, liver and kidney dysfunction, severe osteoporosis, structural heart disease and arrhythmia, pregnancy test positive or breastfeeding women, women and men of recent planning, the non-steroidal anti-inflammatory drugs or cyclomethasone Acid allergy history.

Design outcomes

Primary

MeasureTime frame
Mayo Elbow Performance Score;Amadio elbow ulnar nerve damage evaluation criteria;the MOS item short from health survey, SF-36;

Countries

China

Contacts

Public ContactCunyi Fan

Shanghai Sixth People's Hospital East Campus

fancunyi888@163.com+86 18930177799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026